Skip to main content
Clinical Trials/CTRI/2023/03/050552
CTRI/2023/03/050552
Recruiting
Phase 2

A single arm clinical study to evaluate the efficacy of Shatpushpa arka in Navajaata Kamala (Neonatal Jaundice)

DR NATHE VRISHALI HARISHCHANDRA0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: D50-D89- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Sponsor
DR NATHE VRISHALI HARISHCHANDRA
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
DR NATHE VRISHALI HARISHCHANDRA

Eligibility Criteria

Inclusion Criteria

  • 1 Patient having bilirubin 6 mg/dl To 14 mg/dl
  • 2 The patients presenting the signs and symptoms of Kamala such as pittavarni Netra Mukh Nakh Vinmutra Icterus over body
  • 3 The patients whose parents are ready to participate in the clinical trial by giving informed written consent

Exclusion Criteria

  • 1 Newborn having life threatening illness
  • 2 Newborns who are known cases of chronic systemic illness Like Septicemia

Outcomes

Primary Outcomes

Not specified

Similar Trials